Dr. Mick Peterson, executive director of the Racing Surfaces Testing Laboratory, was on hand at Keeneland the weekend of Oct. 10-11 to review testing and measuring procedures to ensure the safety of the dirt track.
The California Horse Racing Board Oct. 9 said limits on the amount of the trace element cobalt that can be detected in racehorses officially took effect Oct. 5.
A day after prominent trainer Graham Motion questioned the research conducted to determine the threshold level and withdrawal time for methocarbamol (Robaxin), the RMTC defended its efforts.
Keeneland said Oct. 8 it officially is in support of the Thoroughbred Horseracing Integrity Act of 2015 and has joined the Coalition for Horse Racing Integrity, a group that also supports the federal legislation.
The Kentucky Horse Racing Commission has suspended Graham Motion for five days and fined the trainer $500 for a medication overage in Bewitch Stakes (gr. IIIT) winner Kitten's Point. Motion has appealed the ruling.
Ben's Duchess saw the rest of the field sprint away from her early on in the $100,000 LA Woman Stakes (gr. III), but unfurled a late rally to win her first graded stakes Oct. 4 at Santa Anita Park.
The Racing Medication and Testing Consortium has sent Truesdail Laboratories a report listing recommended changes following problems outlined in a July report by the Indiana Horse Racing Commission.
The Food and Drug Administration is seeking the input of equine veterinarians in a study on ruminant and equine anti-parasitic drug use and anti-parasitic resistance.
Old Friends, the Thoroughbred retirement facility near Georgetown, Ky., will launch a special online eBay fundraiser called beginning Sept. 28.
Murphy Farm Hay and Feed Company of Louisburg, N.C., has initiated a voluntary limited recall of alfalfa hay because of potential blister beetle contamination following the deaths of six horses.
The New York State Gaming Commission Sept. 24 passed several rule amendments related to equine medication, including further restrictions on the use of non-steroidal anti-inflammatory drugs and a total ban on stanozolol.
In an Aug. 29 Blood-Horse magazine story, National Thoroughbred Racing Association president Alex Waldrop and other industry leaders assessed the work of the NTRA Safety and Integrity Alliance.
Dr. Scott Morrison, a veterinarian/farrier at Rood & Riddle Equine Hospital in Lexington, is often called upon to care for and shoe foundered horses. Download Now
A Thoroughbred Owners and Breeders Association committee has renewed talks regarding a proposal to phase out use of race-day furosemide in graded stakes.
Churchill Downs announced Sept. 17 that it is working in partnership with other tracks, the Grayson-Jockey Club Research Foundation, and the AAEP to fund studies of the administration of furosemide.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
In the care of Dede McGehee's Heaven Trees Farm near Lexington, broodmare Lotta Kim, dam of 2009 Horse of the Year Rachel Alexandra, is again hitting her stride.
Nearly a month after the California Horse Racing Board hit the brakes on third-party administration of furosemide in the state, the governing body spent just more than a minute to move the process along at a meeting Sept. 16.
The Association of Racing Commissioners International is stepping up efforts to get state regulators to fully adopt the National Uniform Medication Program.
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The United States Anti-Doping Agency says it acted appropriately when allowing Floyd Mayweather to receive an intravenous injection before his May 2 fight with Manny Pacquiao.
The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding potential employment of third-party furosemide administration in the state.
The Ohio State Racing Commission is moving forward with what it has called a comprehensive study into the effects of the mineral cobalt on racehorses.
Horsemen will have the opportunity to pledge a percentage of their total earnings to Thoroughbred Charities of America during the upcoming race meet at Kentucky Downs.
Glenn Blodgett of Guthrie, Texas has been elected to the American Horse Council's Board of Trustees. Blodgett is the current president of the American Quarter Horse Association.
Au Moon, the former resident equine at the Kentucky Derby Museum, was euthanized following surgery for a soft tissue injury he suffered in his first race after coming out of retirement.
The United States Anti-Doping Agency assisted the Drug Enforcement Agency in a nationwide series of enforcement actions targeting the global underground trade of anabolic steroids and other performance-enhancing drugs.
With the year's first major yearling sales in the book and the marathon September sale at Keeneland on the horizon, buyers will be working on where to take the next steps with their purchases. Download Now
The application period for 2016 horse shows to apply for Thoroughbred Incentive Program (T.I.P.) awards is now open and runs through Sept. 30.
The Indiana Horse Racing Commission said Aug. 31 that none of the 221 samples tested for cobalt during the first 60 days of the Indiana Grand Racing & Casino meet were above the published threshold level.
At a Sept. 1 summit presented by the New York State Gaming Commission on racehorse aftercare, the New York Racing Association pledged that it would donate $5 per start at its tracks to the TAA.
The New York Thoroughbred Horsemen's Association Sept. 1 said it will commit $450,000 to acquire state-of-the-art equipment for the New York Equine Drug Testing and Research Program at Morrisville State College.
The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks.
The Louisiana State Racing Commission Aug. 24 adopted the Controlled Therapeutic Medication Schedule of 26 commonly used substances.
A new study funded by the USTA is designed to determine whether the naturally occurring mineral cobalt, when administered in larger, regular doses, has blood-doping qualities and could enhance performance.
Two days after delaying steps to begin third-party administration of race-day furosemide, members of the California Horse Racing Board said they're still in support -- in concept -- of the proposal.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
A three-year effort to employ third-party administration of the race-day medication furosemide in California was delayed significantly at a California Horse Racing Board meeting Aug. 20 at Del Mar.
The Kentucky Horse Racing Commission on Aug. 18 gave final approval to regulations that would provide penalties for excessive levels of the mineral cobalt in post-race tests.
Medication matters dominated the Aug. 18 meeting of the Kentucky Horse Racing Commission, which voted to change the descriptions for the drug classification schedules that are used to determine if a violation has occurred.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
A co-sponsor of federal legislation that would authorize oversight of equine medication and drug-testing said Congress could schedule a committee hearing on the bill this fall. Meanwhile, the debate on the bill continues.
The board of directors of the Thoroughbred Owners and Breeders Association Aug. 12 tackled the issue of whether to support the Thoroughbred Horseracing Integrity Act of 2015.
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
Sam Britt and Michael House's Gabriel Charles will not run in the Arlington Million (gr. IT) after being rushed into emergency colic surgery Aug. 8 at San Luis Rey Equine Hospital in Bonsall, Calif.
The Jockey Club Thoroughbred Safety Committee will implement a centralized database for racehorse necropsy information and has recommended all horses that come off the vet's list be subject to testing.
State-by-state efforts to bring about uniformity in medication policies and drug testing aren't sufficient to move the Thoroughbred industry forward speakers said Aug. 9 at The Jockey Club Round Table conference.
Marc Summers, vice president and general counsel for The Jockey Club, has prepared a side-by-side comparison of two federal bills that propose creating a national program for managing medication use in racehorses.
Continuing his recovery from a hip fracture at Pegasus Equine Rehabilitation and Training Center in Redmond, Wash., Shared Belief still doesn't have a timetable for a return to racing.
When the National Horsemen's Benevolent and Protective Association meets Aug. 6-9 for its summer convention, equine medication will again be a major issue for the organization.
Most Popular Stories
- Jack Milton to be Offered at Fasig-Tipton
- Midas Touch to Rockridge Stud in 2016
- The Week in Photos for 10/13/2015
- Houston Racetrack Owner Dies in Accident
- Claiborne Adds Lea, Announces 2016 Fees
- Bayern's 2016 Fee Announced at $15,000
- Upcoming Open Houses, Stallion Shows
- McGaughey Pleased With Honor Code's Breeze
- Keeneland Racing Surface Procedures Reviewed
- Artemis Agrotera May Return in Breeders' Cup